Antipodes Partners LTD has filed its 13F form on May 06, 2024 for Q1 2024 where it was disclosed a total value porftolio of $3.16 Billion distributed in 72 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Merck & Co., Inc. with a value of $249M, Oracle Corp with a value of $206M, Microsoft Corp with a value of $179M, Occidental Petroleum Corp with a value of $151M, and Amazon Com Inc with a value of $150M.

Examining the 13F form we can see an decrease of $40.1M in the current position value, from $3.2B to 3.16B.

Antipodes Partners LTD is based out at Royal Exchange, C3

Below you can find more details about Antipodes Partners LTD portfolio as well as his latest detailed transactions.

Portfolio value $3.16 Billion
Technology: $625 Million
Healthcare: $478 Million
Basic Materials: $458 Million
Consumer Cyclical: $384 Million
Communication Services: $324 Million
Financial Services: $278 Million
Utilities: $165 Million
Consumer Defensive: $155 Million
Other: $267 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 72
  • Current Value $3.16 Billion
  • Prior Value $3.2 Billion
  • Filing
  • Period Q1 2024
  • Filing Date May 06, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 13 stocks
  • Additional Purchases 18 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 29 stocks
Track This Portfolio

Track Antipodes Partners LTD Portfolio

Follow Antipodes Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Antipodes Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Antipodes Partners LTD with notifications on news.